The HEALEY ALS Platform Trial completes enrollment for testing investigational product ABBV-CLS-7262 from Calico Life Sciences
Enrollment is now complete for Regimen F evaluating ABBV-CLS-7262, an investigational product being developed by Calico Life Sciences LLC (Calico) in collaboration with AbbVie.